Conclusions of Cochrane antioxidants review disputed by Euro and US experts

18 May 2008

Experts from the European Federation of Associations of Health Product Manufacturers' (EHPM) scientific network have raised serious doubts about the evidence to support the negative conclusions of a recently-published meta-analysis on antioxidant supplements.

The study, which was published in the Cochrane Database of Systematic Reviews last month, calls into question the health benefits of antioxidants through its meta analysis of selected clinical trials with antioxidants.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight